WASHINGTON — A top Trump administration official explained a proposed prescription drug price policy during a congressional hearing Tuesday that drew a caution from Colorado U.S. Sen. Michael Bennet.
“There is a complete lack of transparency in this industry, and it’s not just in drugs, it’s everything in health care,” Bennet said.
Until consumers can know the reasons for drug prices, “We’re going to have a hard time making progress,” he said.
He was speaking to Alex Azar, the U.S. Secretary of Health and Human Services, during a hearing to determine what Congress could do to help bring down prescription drug prices.
Lawmakers in Washington Tuesday and the Colorado General Assembly throughout the 2018 session made similar remarks as they blamed pharmaceutical companies for raising prices beyond the ability to pay of many Americans.
Read more at Colorado Politics: https://bit.ly/2y87qvD